1.Effect of Sodium Metavanadate Supplementation on Lipid and Glucose Metabolism Biomarkers in Type 2 Diabetic Patients
Mohammad Afkhami-Ardekani ; Mahdi Karimi ; Seid Mohammad Mohammadi ; Forough Nurani
Malaysian Journal of Nutrition 2008;14(1):113-119
Type 2 diabetes mellitus is a chronic, progressive illness that causes considerable morbidity and premature mortality. Vanadium is a trace mineral that has been
claimed to be effective in controlling blood glucose levels in diabetic patients. A randomised placebo-controlled study was conducted to evaluate the effect of
sodium metavanadate on selected biochemical markers in type 2 diabetic patients. Forty patients were enrolled and half of them received 100 mg sodium
metavanadate daily for 6 weeks while the other half were placebo subjects. The mean age of the patients was 53.1 ± 8.5 years. Body mass index (BMI), blood
pressure(BP), fasting blood sugar (FBS), 2-h postprandial glucose, glycated hemoglobin (HbA1C), triglyceride(TG), total cholesterol (TC), low-density
lipoproteins (LDL), high-density lipoproteins (HDL) were determined before the start and at the end of the study. Levels of FBS, HbA1C, TC and LDL in the
diabetic subjects decreased after six weeks on sodium metavanadate, but the differences were not statistically significant on comparing between pre- and posttrial
levels. Based on the results, this study did not find sodium metavanadate of beneficial use as a form of vanadium supplementation among patients with type
2 diabetes.
2.Understanding Female Students’ Needs to Develop Health Promoting School Programme: An Exploratory Qualitative Analysis
Fatemeh RAKHSHANI ; Ali-Reza Ansari MOGHADDAM ; Fariba SHAHRAKI-SANAVI ; Mahdi MOHAMMADI ; Saeed FAKHRERAHIMI
Malaysian Journal of Medical Sciences 2018;25(2):82-94
Background: This study was carried out on Iranian female adolescents to understandhealth needs for the purpose of designing health promoting intervention in schools.Methods: In this exploratory qualitative study, two focus group discussion (15 teachers)and 30 individual in-depth interviews were conducted among female adolescents in the eighthgrade in Zahedan, Iran. Qualitative content analysis was used for data evaluation.Results: The views of students and teachers demonstrated nine of needs including:informing students about the schools’ health project aims, education and training all dimensionsof health with an emphasis on mental health, use of experts in various fields for education fromother organisations, employing capable and trusted counselors in schools, utilisation of a varietyof teaching methods, activating reward systems for encouraging students’ participation in groupactivities, teaching communication and the ability to establish good relationships with parents andstrategies for resolving family conflict, teaching parents and students high-risk behaviours andstrategies for handling them as well as reforming wrong attitudes and indigenous sub-culture.Conclusion: This study found the different needs of Iranian female students comparedto other cultures about a health promoting school programme. Therefore, their contribution canprovide an insight for formulating policies and intervention in schools.
3.Short-course versus long-course neoadjuvant chemoradiotherapy in patients with rectal cancer: preliminary results of a randomized controlled trial
Mahdi AGHILI ; Nastaran KHALILI ; Neda KHALILI ; Mohammad BABAEI ; Farshid FARHAN ; Peiman HADDAD ; Samaneh SALARVAND ; Amir KESHVARI ; Mohammad Sadegh FAZELI ; Negin MOHAMMADI ; Reza GHALEHTAKI
Radiation Oncology Journal 2020;38(2):119-128
Purpose:
Colorectal cancer is becoming an increasing concern in the middle-aged population of Iran. This study aimed to compare the preliminary results of short-course and long-course neoadjuvant chemoradiotherapy treatment for rectal cancer patients.
Materials and Methods:
Patients in group I received three-dimensional conformational radiotherapy with a dose of 25 Gy/5 fractions in 1 week plus concurrent XELOX regimen (capecitabine 625 mg/m2 from day 1–5 twice daily and oxaliplatin 50 mg/m2 on day 1 once daily). Patients in group II received a total dose of 50–50.4 Gy/25–28 fractions for 5 to 5.5 weeks plus capecitabine 825 mg/m2 twice daily. Both groups underwent delayed surgery at least 8 weeks after radiotherapy completion. The pathological response was assessed with tumor regression grade.
Results:
In this preliminary report on complications and pathological response, 66 patients were randomized into study groups. Mean duration of radiotherapy in the two groups was 5 ± 1 days (range, 5 to 8 days) and 38 ± 6 days (range, 30 to 58 days). The median follow-up was 18 months. Pathological complete response was achieved in 32.3% and 23.1% of patients in the short-course and long-course groups, respectively (p = 0.558). Overall, acute grade 3 or higher treatment-related toxicities occurred in 24.2% and 22.2% of patients in group I and II, respectively (p = 0.551). No acute grade 4 or 5 adverse events were observed in either group. Within one month of surgery, no significant difference was seen regarding grade ≥3 postoperative complications (p = 0.333).
Conclusion
For patients with rectal cancer located 5 cm above the anal verge, short-course radiotherapy with concurrent and consolidation chemotherapy and delayed surgery is not different in terms of acute toxicity, postoperative morbidity, complete resection, and pathological response compared to long-course chemoradiotherapy.